Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (211-220 of 281) with videos related to

Pageof 29
Sort By:
Journal of the American College of Cardiology|April 3, 1998
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring SubstudyA Langer, M W Krucoff, P Klootwijk, et al.
Journal of the American College of Cardiology|July 10, 1999
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implicationsW B Batchelor, E D Peterson, D B Mark, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Journal of Cardiac Failure|May 9, 1998
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial InvestigatorsB M Massie, J G Cleland, P W Armstrong, et al.
Circulation|August 1, 1994
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic EfficacyJ S Steinberg, J S Hochman, C D Morgan, et al.
American Heart Journal|April 27, 2000
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS)P W Armstrong, J R Burton, D Palisaitis, et al.
American Heart Journal|July 1, 1999
Insights into the contemporary epidemiology and outpatient management of congestive heart failureF A McAlister, K K Teo, M Taher, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Pageof 29

Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Journal of the American College of Cardiology|April 3, 1998
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring SubstudyA Langer, M W Krucoff, P Klootwijk, et al.
Journal of the American College of Cardiology|July 10, 1999
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implicationsW B Batchelor, E D Peterson, D B Mark, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Journal of Cardiac Failure|May 9, 1998
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial InvestigatorsB M Massie, J G Cleland, P W Armstrong, et al.
Circulation|August 1, 1994
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic EfficacyJ S Steinberg, J S Hochman, C D Morgan, et al.
American Heart Journal|April 27, 2000
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS)P W Armstrong, J R Burton, D Palisaitis, et al.
American Heart Journal|July 1, 1999
Insights into the contemporary epidemiology and outpatient management of congestive heart failureF A McAlister, K K Teo, M Taher, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Pageof 29